Quality of life in patients with multiple myeloma and malignant lymphoma undergoing autologous progenitor stem cell transplantation: The effect of selected psychosocial and health aspects on quality of life: A retrospective analysis

Reports of Practical Oncology and Radiotherapy

Volumn 12, Issue 2, 2007, Pages 101-108

  Slovacek, Ladislav ^a,b,c,d   Slovackova, Birgita ^b   Blazek, Martin ^b   Jebavy, Ladislav ^a,b  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Autologous progenitor stem cell transplantation; Malignant lymphoma; Multiple myeloma; Quality of life

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 34250730248     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(10)60046-6     Document Type: Article

References (24)

1. st ed. Praque, Galen, 2001; 138-41
2. Slovacek L, Slovackova B, Jebavy L: Global Quality of Life in Patients Who Have Undergone the Hematopoietic Stem Cell Transplantation: Finding from Transversal and Retrospective Study. Exp Oncol, 2005, 27(3): 238-42
3. Salajka F: Quality of Life of Oncological Patients. Journal of Czech and Slovak Clinical Oncology, 2001; 1: 27-29
4. nd ed. Jones and Bartlett Publishers, 2003; 455-65
5. Grant M, Ferrell B, Schmidt GM et al: Measurement of quality of life in bone marrow transplantat survivors. Qual Life Res, 1992; 1(6): 375-84
6. The EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy, 1990; 16(3): 199-208
7. De Souza CA, Duraes MI, Vigorito AC: Quality of life in patients randomized to receive a bone marrow or a peripheral blood transplantation. Haematologica 2002, 87(12): 1281-85
8. Heinonen H, Volin L, Uutela A: Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant, 2001; 28(5): 503-9
9. Heinonen H, Volin L, Uutela A: Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol, 2001; 80(3): 137-43
10. Chiodi S, Spinelli S, Ravera C: Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol, 2000; 10(3): 614-19
11. Wang WQ Lin GW: Study on quality of life in long-term survivors with acute leukemia in Shanghay. Zhonghua Liu Xing Bing Xue Za Zhi, 2003; 24(11): 1049-51
12. Wong R, Giralt SA, Martin T: Reduced-intensity conditioning for unrelated donor hematopoetic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. Blood, 2003; 102(8): 3052-9
13. Andrykowski MA, Greiner CB, Altmaier EM: Quality of life following bone marrow transplantation: finding from a multicentre study. J Cancer, 1995; 71(6): 1322-29
14. Zittoun R, Achard S, Ruszniewski M: Assessement of quality of life during intensive chemotherapy bone marrow transplantation. Psychooncology, 1999; 8(1): 64-73
15. So WK, Dodgson J, Tai JW: Fatigue and quality of life among Chinese patients with hematologic malignancy and bone marrow transplantation. Cancer Nurs, 2003; 26(3): 211-19
16. Saleh US, Brockopp DY: Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplantation survivors tool. Oncol Nurs Forum, 2001; 28(9): 1457-64
17. Kouroukis T, Meyer R, Benger A et al: An evaluation of age-related differences in quality of life preferences in patinets with non-Hodgkins lymphoma. Leuk Lymphoma, 2004; 45(12): 2471-6
18. Chang G, Orav EJ, Tong MY, Antin JH: Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics, 2004; 45(5): 378-85
19. Poulos AR, Gertz MA, Pankratz VS, Post-White J: Pain, mood disturbance, and quality of life patients with multiple myeloma. Oncol Nurs Forum, 2001; 28(7): 1163-71
20. Holzner B, Kemmler G, Sperner-Unterweger B et al: Quality of life measurement in oncology - a matter of the assessment instrument ? Eur J Cancer, 2001; 37(18): 2349-56
21. Van Agthoven M, Vellengs E, Fibbe WE: Cost analysis and quality of life assessment comparing undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkins lymphoma or Hodgkins disease, a prospective randomised trial. Eur J Cancer, 2001; 37(14): 1781-9
22. Mounier N, Haioun C, Cole BF et al: Quality of life adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe dÉtude les Lymphomes de lÁdult (GELA). Blood, 2000; 95(12): 3687-92
23. Mesanyova M, Simek J: Bone Marrow Transplant from Patients Overview. Czech Pract, 2004; 84(9): 536-40
24. Adam Z, Pour L, Svobodnik A et al: Quality of life and tolerance of maintenance therapy in patients with multiple myeloma. Czech Journal of Internal Medicine, 2002; 48(3): 216-29